Regional Access Manager - Central

The Regional Access Manager (RAM) is required to lead & implement the regional access strategy with a broad range of payer customers in order to achieve or improve access for Galderma's Dermatology portfolio including a specific focus on the new Biologic. The RAM will work in close collaboration and partnership with the commercial head office and commercial field-based teams to achieve success.,

• Ensure appropriate and consistent patient access to Galderma medicines within the regional payer including local ICSs and Trusts.
• Achieve optimal positioning of Galderma medicines within local/regional commissioning guidelines through communicating a robust Payor Value Proposition.
• Enable optimisation of funding and patient throughput for service elements (eg patient pathways) in Dermatology
• Leading & implementing the regional market access strategy for new launch biologic in Dermatology
• Mapping out and developing strong working relationships with relevant local/regional NHS, ICS commissioning personnel to enable implementation of access strategies
• Support the timely inclusion of Galderma medicines onto local & regional formularies and clinical guidelines at ICS /Trust payor level
• Removal of any regional or local barriers to patient access
• Responsibility for developing a deep understanding of the regional (ICS) policy & payer environment and a deep understanding of local NHS priorities - bringing insight into the organisation as to how these areas are commissioned, what key local access barriers and recommendations as to how key challenges can be resolved
• Scoping out the potential opportunities for Galderma within the changing NHS environment including integrated health care organisations - reflecting back recommendations to the brand teams and identifying the key decision makers with whom interactions should occur
• The ability to develop, articulate and refine brand value propositions through use of approved Payer Tools and messaging
• Responsible for developing and sustaining highly effective, well informed, credible, productive, and compliant working relationships between Galderma and our external stakeholders
• Close proactive collaboration with cross functional teams to ensure alignment between national and regional/local plans.
• Identification of prioritised and XFT agreed opportunities where then new dermatology biolgic is optimally positioned on clinical pathways to optimise funding and patient throughput for service elements (eg patient pathways) in the therapeutic areas within which (Galderma) works (ICS / Trust)
• Proactively seeks to understand competitor activities, strategies, and programs and ensure that this competitive intelligence is shared broadly within the organisation.
• Ensure a close cooperative productive working relationship with colleagues in other teams e.g. other Commercial, Medical etc. to manage opportunities to ensure the successful implementation of all possible synergies
  
  Can think independently and act autonomously.
• Qualified to degree level in relevant discipline
• 3-5 years market access experience in high costs drugs including launch experience.
• Proven delivery of successful outcomes with payors
• Experience working the therapeutic areas of Immunology and with established relationships within the local health economy
• Drive for self-development with a solution & action-oriented work ethic.
• Proven clear, concise communication, influencing, and negotiating skills
• Proven key account & project management skills & ability to prioritise and manage complex projects
• Demonstrable ability to work collaboratively & cross functionally
• Ability to think strategically & execute tactically
• Ability to lead and influence without authority, respond, and adapt to the needs & requirements of the business
• Good knowledge of UK healthcare landscape, including national & local payors, providers and healthcare funding flows and ability to turn knowledge into insights
• Proven experience of interacting with and shaping relationships directly with healthcare stakeholders, especially payors
• Experience working in a payor organisation is desirable
• Knowledge of payor decision making process and who are the key payor stakeholders
• Microsoft Fluent
• Proficiency in speaking, comprehending, reading, and writing English is required.
• ABPI qualified, At Galderma, you'll work with people who are like you. And people that are different. We value what every member of our team brings. Professionalism, collaboration, and a friendly, supportive ethos is the perfect environment for people to thrive and excel in what they do.
  
  Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ - the skin - meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin, we are in shapes our lives, we are advancing dermatology for every skin story.
We look for people who focus on getting results, embrace learning and bring a positive energy. They must combine initiative with a sense of teamwork and collaboration. Above all, they must be passionate about doing something meaningful for consumers, patients, and the healthcare professionals we serve every day. We aim to empower each employee and promote their personal growth while ensuring business needs are met now and into the future. Across our company, we embrace diversity and respect the dignity, privacy, and personal rights of every employee. At Galderma, we actively give our teams reasons to believe in our bold ambition to become the leading dermatology company in the world. With us, you have the ultimate opportunity to gain new and challenging work experiences and create an unparalleled, direct impact., Its an exciting time for Galderma as we enter the biologics market in Dermatology with a new asset/ mode of action which will be indicated for Atopic Dermatitis and Prurigo Nodularis, this is Galderma's first entrance into the Dermatology Speciality area which brings a real sense of opportunity for the organisation to establish themselves within this competitive market.